Spruce Biosciences Inc. (NASDAQ:SPRB) went up by 7.03% from its latest closing price compared to the recent 1-year high of $28.49. The company’s stock price has collected -2.61% of loss in the last five trading sessions. Press Release reported on 01/06/22 that Thinking about buying stock in Spruce Biosciences, Occidental Petroleum, Uranium Energy, Somalogic, or Ree Automotive?
Is It Worth Investing in Spruce Biosciences Inc. (NASDAQ :SPRB) Right Now?
Opinions of the stock are interesting as 5 analysts out of 7 who provided ratings for Spruce Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 2 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $11.00, which is $6.89 above the current price. SPRB currently public float of 4.09M and currently shorts hold a 16.58% ratio of that float. Today, the average trading volume of SPRB was 3.78M shares.
SPRB’s Market Performance
SPRB stocks went down by -2.61% for the week, with a monthly jump of 63.10% and a quarterly performance of -18.13%, while its annual performance rate touched -81.10%. The volatility ratio for the week stands at 14.44% while the volatility levels for the past 30 days are set at 22.69% for Spruce Biosciences Inc.. The simple moving average for the period of the last 20 days is 7.28% for SPRB stocks with a simple moving average of -53.22% for the last 200 days.
Analysts’ Opinion of SPRB
Many brokerage firms have already submitted their reports for SPRB stocks, with Oppenheimer repeating the rating for SPRB by listing it as a “Outperform.” The predicted price for SPRB in the upcoming period, according to Oppenheimer is $15 based on the research report published on December 17th of the previous year 2021.
The Benchmark Company, on the other hand, stated in their research note that they expect to see SPRB reach a price target of $7. The rating they have provided for SPRB stocks is “Speculative Buy” according to the report published on December 10th, 2021.
SPRB Trading at 14.39% from the 50-Day Moving Average
After a stumble in the market that brought SPRB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.57% of loss for the given period.
Volatility was left at 22.69%, however, over the last 30 days, the volatility rate increased by 14.44%, as shares surge +65.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.66% lower at present.
During the last 5 trading sessions, SPRB fell by -2.61%, which changed the moving average for the period of 200-days by -72.23% in comparison to the 20-day moving average, which settled at $3.91. In addition, Spruce Biosciences Inc. saw -7.85% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at SPRB starting from SIMPSON CAMILLA V, who sale 334 shares at the price of $15.29 back on May 20. After this action, SIMPSON CAMILLA V now owns 0 shares of Spruce Biosciences Inc., valued at $5,107 using the latest closing price.
Novo Holdings A/S, the 10% Owner of Spruce Biosciences Inc., sale 475,000 shares at $13.90 during a trade that took place back on May 19, which means that Novo Holdings A/S is holding 4,514,336 shares at $6,602,500 based on the most recent closing price.
Stock Fundamentals for SPRB
Equity return is now at value -30.70, with -27.80 for asset returns.